J&J | JNJ - Loan Capital


J&J reported $37.53B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Abbott USD 29.64B 19.74B Mar/2026
Amgen USD 51.89B 1.88B Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
CONMED USD 834.23M 18.78M Dec/2025
Cooper Companies USD 1.86B 17.7M Mar/2026
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Eli Lilly USD 39.37B 1.5B Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merck USD 46.67B 77M Mar/2026
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 601.77M 291.73M Mar/2026
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026
Zoetis USD 9.04B 3M Mar/2026